Abstract
The fibrinolytic response of 30 diabetic patients and 35 non-diabetics to 0·5 mg. subcutaneous adrenaline was measured, using the dilute clot lysis test. With the exception of two patients out of six who were taking phenformin, who had a depressed response, the diabetics showed a similar increase in fibrinolytic activity to the non-diabetics. The diabetics in this series did not tend to have longer spontaneous lysis times than the non-diabetics, although this type of comparison may not be valid.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- DENBOROUGH M. A., PATERSON B. Clearing factor, fibrinolysis and blood lipids in diabetes mellitus. Clin Sci. 1962 Dec;23:485–488. [PubMed] [Google Scholar]
- FEARNLEY G. R., CHAKRABARTI R. THE PHARMACOLOGICAL ENHANCEMENT OF BLOOD FIBRINOLYTIC ACTIVITY WITH SPECIAL REFERENCE TO PHENFORMIN. Acta Cardiol. 1964;19:1–13. [PubMed] [Google Scholar]
- FEARNLEY G. R., VINCENT C. T., CHAKRABARTI R. Reduction of blood fibrinolytic activity in diabetes mellitus by insulin. Lancet. 1959 Dec 12;2(7111):1067–1067. doi: 10.1016/s0140-6736(59)91534-x. [DOI] [PubMed] [Google Scholar]
- MACKAY N., HUME R. FIBRINOLYTIC ACTIVITY IN DIABETES MELLITUS. Scott Med J. 1964 Sep;9:359–364. doi: 10.1177/003693306400900901. [DOI] [PubMed] [Google Scholar]
- TANSER A. R., SMELLIE H. OBSERVATIONS ON ADRENALINE-INDUCED FIBRINOLYSIS IN MAN. Clin Sci. 1964 Jun;26:375–380. [PubMed] [Google Scholar]